Publications

5674 Results

Germline genetic variants in GATA3 and breast cancer treatment outcomes in SWOG S8897 trial

Authors
V Larsen;W Barlow;JJ Yang;Q Zhu;S Liu;LF Hutchins;S Kadlubar;K Albain;RB Livingston;JM Rae;I-T Yeh;PM Ravdin;S Martino;A Lyss;CK Osborne;G Hortobagyi;DF Hayes;CB Ambrosone;S Yao
Journal / Conference
American Association for Cancer Research Annual Meeting (April 16-20, 2016, New Orleans, LA), abst #2032, poster
Year
2016
Research Committee(s)
Breast
Study Number(s)
SWOG-8897

Effect of long-term vitamin E and selenium supplementation on urine F2-Isoprostanes, a biomarker of oxidative stress

Authors
K Guertin;R Grant;K Arnold;L Burwell;J Hartline;P Goodman;L Minasian;S Lippman;E Klein;P Cassano
Journal / Conference
Free Radical Biology and Medicine, Jun;95:349-356; 2016 Mar 22 [Epub ahead of print]
Year
2016
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID27012420
PMC
PMC4867301
Study Number(s)
S0000C

Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226

Authors
D Hertz;W Barlow;K Kidwell;K Albain;T Vandenberg;S Dakhil;N Tirumali;R Livingston;J Gralow;D Hayes;G Hortobagyi;R Mehta;J Rae
Journal / Conference
British Journal of Clinical Pharmacology Jun;81(6):1134-1141; 2016 Feb 9 [Epub ahead of print]
Year
2016
Research Committee(s)
Breast
PMID
PMID26859101
PMC
PMC4876171
Study Number(s)
S0226

Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to finasteride in the Prostate Cancer Prevention Trial

Authors
D Winchester;C Till;P Goodman;C Tangen;R Santella;R Leach;J Xu;S Zheng;I Thompson;M Lucia;S Lippman;H Parnes;W Isaacs;A De Marzo;C Drake;E Platz
Journal / Conference
American Association for Cancer Research Annual Meeting (April 16 - 20, 2016, New Orleans, LA), abst #812, poster
Year
2016
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Supplement use and chemotherapy-induced peripheral neuropathy in breast cancer patients treated on SWOG study S0221

Authors
G Zirpoli;S McCann;L Sucheston-Campbell;D Hershman;G Ciupak;W Davis;J Unger;H Moore;J Stewart;C Isaacs;T Hobday;M Salim;R Livingston;G Hortobagyi;D Hayes;G Budd;K Albain;C Ambrosone
Journal / Conference
American Association for Research Annual Meeting (April 16 - 20, 2016, New Orleans, LA), abst #3413, poster
Year
2016
Research Committee(s)
Breast
Study Number(s)
S0221

Molecular characterization of follicular lymphoma patients enrolled on SWOG S0016 using FFPE Chromosomal Genomic Array Testing

Authors
X Qu;H Li;O Press;L Rimsza;R Braziel;M Leblanc;E Hsi;S Smith;J Friedberg;M Fang
Journal / Conference
Annual Clinical Genetics Meeting of the American College of Medical Genetics and Genomics ( March 8-12, 2016, Tampa, FL), poster, abst #141 (https://acmg.expoplanner.com/index.cfm?do=expomap.sess&event_id=7&session_id=1668)
Year
2016
Research Committee(s)
Lymphoma
Study Number(s)
S0016

Variants associated with high grade bevacizumab-induced hypertension identified by exome sequencing: CALGB 80405 (Alliance).

Authors
M Li;F Mulkey;C Jiang;B O'Neil;D Niedzwiecki;P Friedman;H Hochster;H Lenz;A Venook;K Owzar;D Kroetz
Journal / Conference
American Society for Clinical Pharmacology and Therapeutics (March 8-12, San Diego, CA), late breaking poster session abst. #LB-041, p. 164
Year
2016
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405

Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials

Authors
D Hershman;C Till;J Wright;D Awad;S Ramsey;W Barlow;L Minasian;J Unger
Journal / Conference
Journal of Clinical Oncology Sep 1;34(25):3014-3022; 2016 Jun 20 [Epub ahead of print]
Year
2016
Research Committee(s)
Breast, Genitourinary, Gynecologic, Head and Neck, and Lung
PMID
PMID27325863
PMC
PMC5012713
Study Number(s)
S0003, S0007, S0009, S0012, S0022, S0023, S0027, S0028, S0029, S0032, S0102, S0219, S0221, S0329, S0421, S0536, S0819, S9712, S9900, S9902, S9912, S9914, S9916

Long-term consequences of intervention following receipt of finasteride or placebo in the Prostate Cancer Prevention Trial (SWOG S9217)

Authors
J Unger;C Till;I Thompson;C Tangen;P Goodman;J Wright;W Barlow;S Ramsey;L Minasian;D Hershman
Journal / Conference
Journal of the National Cancer Institute Aug 26;108(12). pii: djw168. doi: 10.1093/jnci/djw168.
Year
2016
Research Committee(s)
Cancer Control
PMID
PMID27565902
PMC
PMC5241895
Study Number(s)
SWOG-9217

Peripheral zone inflammation is not strongly associated with lower urinary tract symptom incidence and progression in the placebo arm of the Prostate Cancer Prevention Trial

Authors
I Kulac;B Gumuskaya;C Drake;B Gonzalez;K Arnold;P Goodman;A Kristal;MS Lucia;IM Thompson;WB Isaacs;AM De Marzo;E Platz
Journal / Conference
Prostate Nov;76(15):1399-1408; 2016 Jun 21 [Epub ahead of print]
Year
2016
Research Committee(s)
Cancer Control
PMID
PMID27325488
PMC
PMC5497457
Study Number(s)
SWOG-9217